Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 7, 2020; 26(41): 6488-6509
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6488
Published online Nov 7, 2020. doi: 10.3748/wjg.v26.i41.6488
Table 5 Risk ratios with 95% confidence interval of adverse effects
| RPs | |||||
| 0.99 (0.35, 2.81) | Placebo | ||||
| 0.85 (0.45, 1.59) | 0.86 (0.37, 1.97) | BFT | |||
| 0.39 (0.02, 9.12) | 0.39 (0.01, 10.93) | 0.46 (0.02, 11.47) | Moxibustion | ||
| 0.50 (0.13, 1.89) | 0.51 (0.22, 1.15) | 0.59 (0.18, 1.90) | 1.29 (0.04, 39.33) | Probiotics | |
| 0.40 (0.09, 1.88) | 0.41 (0.06, 2.62) | 0.47 (0.09, 2.51) | 1.03 (0.07, 16.13) | 0.80 (0.10, 6.13) | Acupuncture |
- Citation: Dai YK, Wu YB, Li RL, Chen WJ, Tang CZ, Lu LM, Hu L. Efficacy and safety of non-pharmacological interventions for irritable bowel syndrome in adults. World J Gastroenterol 2020; 26(41): 6488-6509
- URL: https://www.wjgnet.com/1007-9327/full/v26/i41/6488.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i41.6488